Monocyte-mediated acute renal rejection after combined treatment with preoperative Campath-1H (alemtuzumab) and postoperative immunosuppression

Annals of Clinical and Laboratory Science

Volumn 34, Issue 2, 2004, Pages 209-213

  Zhang, Ping L ^a   Malek, Sayeed K ^a   Prichard, Jeffery W ^a   Lin, Fan ^a   Yahya, Taher M ^a   Schwartzman, Michael S ^a   Latsha, Ruth P ^a   Skaletsky, Marybess ^a   Norfolk, Evan R ^a   Brown, Robert E ^a   Hartle, James E ^a   Potdar, Santosh ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Acute transplant rejection; Campath 1H; CD52; Monocytes; Renal transplantion

Indexed keywords

ALEMTUZUMAB; CD3 ANTIGEN; CD34 ANTIGEN; CD52 ANTIGEN; CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; T6 ANTIGEN;

ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DENDRITIC CELL; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; MALE; MONOCYTE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; STEROID THERAPY; T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, NEOPLASM; DRUG THERAPY, COMBINATION; GLYCOPROTEINS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MONOCYTES; MYCOPHENOLIC ACID; POSTOPERATIVE CARE; PREDNISONE; PREOPERATIVE CARE;

EID: 2542467974     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Calne R, Friend P, Moffatt S, Bradley A, Hale G, Firth J, Bradley J, Smith K, Waldmann H. Prope tolerance, perioperative Campath 1H, and low-dose cyclosporin immunotherapy in renal allograft recipients. Lancet 1998;351:1701-1702.
2. Kirk AD, Hale DA, Mannon RB, Kleiner DE, Hoffman SC, Kampen RL, Cendales LK, Tadaki DK, Harlan DM, Swanson SJ. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H). Transplantation 2003;76:120-129.
3. Buggins AG, Mufti GJ, Salisbury J, Codd J, Westwood N, Arno M, Fishlock K, Pagliuca A, Devereux S. Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab. Blood 2002;100:1715-1720.
4. Ratzinger G, Reagan JL, Heller G, Busam KJ, Young JW. Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation. Blood 2003; 101:1422-1429.
5. Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, Corry RJ, Jordan ML, Fontes P, Gayowski T, Bond G, Scantlebury VP, Potdar S, Randhawa P, Wu T, Zeevi A, Nalesnik MA, Woodward J, Marcos A, Trucco M, Demetris AJ, Fung JJ. Tolerogenic immunosuppression for organ transplantation. Lancet 2003;361:1502-1510.
6. Chandraker A, Perkins DL, Carpenter CB, Sayegh MH. Transplantation immunobiology, In: The Kidney, 7th ed, (Brenner BM, Ed), Saunders, Philadelphia, 2004; Chap 63, pp 2759-2783.
7. Grau V, Garn H, Bette M, Spener F, Steiniger B, Gemsa D, Stehling O. Induction of epidermal fatty acid binding protein in intravascular monocytes of renal allografts. Transplantation 2003;75:685-688.
8. Grone HJ, Weber C, Weber KS, Grone EF, Rabelink T, Klier CM, Wells TN, Proudfood AE, Schlondorff D, Nelson PJ. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 1999;13:1371-1383.
9. Oliveira JG, Xavier P, Neto S, Mendes AA, Guerra LE. Monocytes-macrophages and cytokine/chemokines in fine needle aspiration biopsy cultures: enhanced interleukin-1 receptor antagonist synthesis in rejection-free kidney transplant patients. Transplantation 1997;63:1751-1756.
10. Robinson SP, Patterson S, English N, Davies D, Knight SC, Reid CD. Human peripheral blood contains two distinct lineages of dendritic cells. Europ J Immunol 1999;29:2769-2778.
11. Sarwal M, Chua M-S, Kambham N, Hsieh S-C, Satterwhite T, Masek M, Salvatierra O. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. NEJM 2003;349:125-138.